Cyclodextrins in oligonucleotide delivery (Q34455188)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Cyclodextrins in oligonucleotide delivery	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Cyclodextrins in oligonucleotide delivery (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Redenti E

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pietra C

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gerloczy A

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Szente L

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Advanced Drug Delivery Reviews

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

235-244

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligonucleotides: a new therapeutic principle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligodeoxynucleotides as clinical therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense approaches for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligonucleotides as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta globin gene inhibition by antisense RNA transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA antisense therapy for asthma in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CRE-decoy oligonucleotide-inhibition of gene expression and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: protein kinase A downregulation and cytoplasmic export of CRE-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligonucleotide therapeutics--novel cardiovascular targets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory gene therapy directed at the airway epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory DNA: a clear and present danger?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense technology for cancer therapy: does it make sense?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic oligonucleotides as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense strategy: biological utility and prospects in the treatment of hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

As nature intended? The uptake of DNA and oligonucleotides by eukaryotic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the terminal phosphate derivatization of beta- and alpha-oligodeoxynucleotides on their antisense activity in protein biosynthesis, stability and uptake by eucaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposomes revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposomal targeting of bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Introduction and General Overview of Cyclodextrin Chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclodextrins in peptide and protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intestinal safety of water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: effects on human intestinal epithelial Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) following intranasal administration in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclodextrins in nasal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chiral separation of antisense oligonucleotides: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis, Hybridization Properties, Nuclease Stability, and Cellular Uptake of the Oligonucleotide-Amino-.beta.-cyclodextrins and Adamantane Conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Downregulation of the p75 neurotrophin receptor in tissue culture and in vivo, using beta-cyclodextrin-adamantane-oligonucleotide conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of oligonucleotide-induced immune stimulation by cyclodextrin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-Cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of sodium glycocholate and other additives on the in vivo transfection of plasmid DNA in the lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New class of polymers for the delivery of macromolecular therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900230-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-409X(01)00230-7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34455188&oldid=1551468235"